SCHEMBL22758513

SCHEMBL22758513

COC(=O)C1(c2nccc(SC)n2)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ PKM P14618 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ TBK1 Q9UHD2 1/20 0.38
▸ DDB1 Q16531 1/20 0.38
▸ CRBN Q96SW2 1/20 0.38
▸ GPR119 Q8TDV5 4/20 0.38
▸ NAMPT P43490 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28944831 0.81 ATM (0.42) TSHRALOX15ATMPKMACHE
SCHEMBL22758511 0.78 CYP2C19 (0.36) TSHRPKMPOLB
SCHEMBL22749385 0.77 POLB (0.44) TSHRALOX15ATMPKMACHE
SCHEMBL31382726 0.75 TSHR (0.51) TSHRALOX15ATMPKMGPR119
SCHEMBL22770324 0.75 POLB (0.47) TSHRALOX15ATMPKMPOLB
SCHEMBL11963328 0.74 PKM (0.44) TSHRALOX15ATMPKMGPR119
SCHEMBL22792894 0.74 POLB (0.48) TSHRALOX15ATMPKMPOLB
SCHEMBL31382411 0.73 TSHR (0.49) TSHRALOX15ATMGPR119
SCHEMBL31382020 0.73 TSHR (0.51) TSHRALOX15ATM
SCHEMBL21392144 0.73 CTPS1 (0.60) TSHRALOX15ATMDDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020245664-A1 N-(5-(6-ETHOXYPYRAZIN-2-YL)PYRIDIN-2-YL)-4-(2-(METHYLSULFONAMIDO)PYRIMIDIN-4-YL) TETRAHYDRO-2H-PYRAN-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HUMAN CTPS1 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES STEP PHARMA S.A.S. (FR) 2020-12-10 — — WO disclosed
Send feedback